Candesartan vs Nivolumab

## Candesartan vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Candesartan** and **Nivolumab**.

## Mechanism of Action

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Candesartan — 9 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Candesartan — C33H34N6O6; Nivolumab — N/A.

**Molecular Weight**: Candesartan — 610.6640 g/mol; Nivolumab — N/A.

**Type**: Candesartan — Small molecule; Nivolumab — Antibody.